RESUMEN
BACKGROUND: Contact with animals and their environment has long been recognized as an important source of enteric zoonoses. However, there are limited data available on the burden of illness associated with specific types of animals in Canada. This study describes the overall burden of enteric zoonoses in Ontario, Canada from 2010 to 2012. METHODS: Confirmed cases of seven enteric zoonotic diseases (campylobacteriosis, cryptosporidiosis, giardiasis, listeriosis, salmonellosis, verotoxin-producing E. coli (VTEC) infection, and yersiniosis) with episode dates from 2010 to 2012 were extracted from the integrated Public Health Information System (iPHIS). Reported exposures were categorized as animal contact, foodborne, waterborne and 'other', with animal contact grouped into nine sub-categories based on the type of animal or transmission setting. Overall incidence rates and proportions by animal exposure categories, age and sex-specific incidence rates and hospitalization and death proportions were calculated and sex proportions compared. RESULTS: Our study found that approximately 26% of the enteric pathogens assessed during the 2010 to 2012 period reported contact with animals and their environments as the mode of transmission. Of enteric disease cases reporting animal contact, farm exposures were reported for 51.3%, dog or cat exposures for 26.3%, and reptile or amphibian exposures for 8.9%. CONCLUSIONS: Contact with animals was reported more frequently during the period 2010 to 2012 in comparison to the period 1997 to 2003 when 6% or less of enteric cases were associated with animal contact. Public health professionals, stakeholders associated with animals and their related industries (e.g., pet treats, mobile zoos, abattoirs), and the public should recognize that animal contact is an important source of enteric illnesses in order to take measures to reduce the burden of illness from animal sources.
Asunto(s)
Animales Domésticos/microbiología , Salud Pública , Zoonosis/epidemiología , Animales , Infecciones por Campylobacter/epidemiología , Gatos , Vectores de Enfermedades/clasificación , Perros , Femenino , Giardiasis/epidemiología , Humanos , Masculino , Ontario/epidemiología , Estaciones del Año , Zoonosis/parasitologíaRESUMEN
OBJECTIVE: In 2014/2015, Public Health Ontario developed disease-specific, cumulative sum (CUSUM)-based statistical algorithms for detecting aberrant increases in reportable infectious disease incidence in Ontario. The objective of this study was to determine whether the prospective application of these CUSUM algorithms, based on historical patterns, have improved specificity and sensitivity compared to the currently used Early Aberration Reporting System (EARS) algorithm, developed by the US Centers for Disease Control and Prevention. METHOD: A total of seven algorithms were developed for the following diseases: cyclosporiasis, giardiasis, influenza (one each for type A and type B), mumps, pertussis, invasive pneumococcal disease. Historical data were used as baseline to assess known outbreaks. Regression models were used to model seasonality and CUSUM was applied to the difference between observed and expected counts. An interactive web application was developed allowing program staff to directly interact with data and tune the parameters of CUSUM algorithms using their expertise on the epidemiology of each disease. Using these parameters, a CUSUM detection system was applied prospectively and the results were compared to the outputs generated by EARS. The outcome was the detection of outbreaks, or the start of a known seasonal increase and predicting the peak in activity. RESULTS: The CUSUM algorithms detected provincial outbreaks earlier than the EARS algorithm, identified the start of the influenza season in advance of traditional methods, and had fewer false positive alerts. Additionally, having staff involved in the creation of the algorithms improved their understanding of the algorithms and improved use in practice. CONCLUSION: Using interactive web-based technology to tune CUSUM improved the sensitivity and specificity of detection algorithms.
Asunto(s)
Algoritmos , Enfermedades Transmisibles/epidemiología , Brotes de Enfermedades/prevención & control , Internet , Vigilancia de la Población/métodos , Interfaz Usuario-Computador , Humanos , Incidencia , Ontario/epidemiología , Estudios ProspectivosRESUMEN
BACKGROUND: The disease of chronic lymphocytic leukemia (CLL) has been shown to exhibit varying clinical outcomes based on reported laboratory parameters. One of these parameters involves the measurement of the protein levels of zeta-associated protein (ZAP-70) in CLL cells. A standardized assay has not yet reached consensus in the clinical cytometry community. METHODS: We developed a system using the 8-peak Rainbow beads as our fluorescence calibrator along with a fixed cell control. Using a panel of CD19-PE, CD5-FITC, and ZAP-70-Alexa 647, we stained normal whole blood, and blood and bone marrow from patients with CLL to determine the level of ZAP-70 expression in T-cell, B-cell, and CLL-cell populations. ZAP-70 expression was reported in molecules equivalent fluorescence (MEFL) based on the calibration of the flow cytometer with the 8-peak Rainbow beads. RESULTS: Daily assay performance as well as operating MEFL defined ranges for ZAP-70 detection in CLL were developed. A rank-order, nonparametric approach to reference ranges was used to assign a cutoff for "negative" as well as ranges for "intermediate" and "positive" staining using T and B cells from a pool of 50 normal subjects, and CLL cells from 395 patients. The assay was validated in a multi-institutional study and has demonstrated correlation with published techniques. Since its initial development, the assay has been implemented at two additional laboratory sites and has been shown to produce reproducible, correlated data at all sites. CONCLUSIONS: Strict adherence to standardization can yield an assay that is predictable, reliable, and reproducible as well as capable of multisite implementation. The Rainbow beads provide a common platform for system calibration. The fixed cell culture controls provide a common target to test antibody. The final level of control tests the sensitivity of ZAP-70 detection in a normal peripheral blood sample stained along with the submitted CLL patients. The acceptance/rejection of test results must meet all three levels of control before patient results are reported.